MEDICINOVA INC (MNOV) Stock Balance Sheet
NASDAQ:MNOV • US58468P2065
Current stock price
1.56 USD
+0.17 (+12.23%)
At close:
1.58 USD
+0.02 (+1.28%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 30.81M | 40.36M | 51.00M | 18.50M | 71.40M | |||
| Marketable Securities | N/A | N/A | 0.00 | 40.00M | N/A | |||
| Other Current Assets | 184.80K | 714.50K | 174.90K | 500.00K | 600.00K | |||
| Total Current Assets | 30.99M | 41.07M | 51.17M | 59.00M | 72.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 192.60K | 382.40K | 621.20K | 700.00K | 900.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 9.60M | 9.60M | 9.60M | 9.60M | 9.60M | |||
| Intangibles | 4.80M | 4.80M | 4.80M | 4.80M | 4.80M | |||
| Other Non-Current Assets | 19.00K | 19.00K | 74.10K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 14.61M | 14.80M | 15.10M | 15.20M | 15.40M | |||
| TOTAL ASSETS | 45.60M | 55.88M | 66.27M | 74.20M | 87.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.80M | 1.86M | 2.28M | 2.80M | 2.40M | |||
| Accounts Payable | 625.00K | 1.10M | 1.00M | 400.00K | 400.00K | |||
| Other Current Liabilities | 370.20K | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.80M | 2.96M | 3.28M | 3.20M | 2.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 201.80K | 201.80K | 201.80K | 200.00K | 200.00K | |||
| Other Non-Current Liabilities | 17.10K | 211.50K | 410.70K | 500.00K | 700.00K | |||
| Total Non-Current Liabilities | 218.90K | 413.30K | 612.50K | 700.00K | 900.00K | |||
| TOTAL LIABILITIES | 4.02M | 3.37M | 3.89M | 3.90M | 3.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -438.75M | -426.75M | -415.70M | -407.10M | -393.10M | |||
| Additional Paid In Capital | 480.41M | 479.34M | 478.15M | 477.40M | 476.80M | |||
| Common Shares | 49.20K | 49.10K | 49.10K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -127.20K | -135.20K | -118.10K | -100.00K | -100.00K | |||
| Shares Outstanding | 49.22M | 49.05M | 49.05M | 49.00M | 49.00M | |||
| Tangible Book Value per Share | 0.55 | 0.78 | 0.98 | 1.14 | 1.41 | |||
| Total Shareholders' Equity | 41.59M | 52.50M | 62.38M | 70.20M | 83.70M | |||
| TOTAL LIABILITIES AND EQUITY | 45.60M | 55.88M | 66.27M | 74.20M | 87.40M | |||
| Statistics | ||||||||
| Current Ratio | 8.16 | 13.88 | 15.61 | 18.44 | 25.71 | |||
| Return On Assets (ROA) | -26.31% | -19.78% | -12.93% | -18.96% | -11.59% | |||
| Return On Equity (ROE) | -28.85% | -21.05% | -13.74% | -20.04% | -12.10% | |||
All data in USD , ROIC based on taxRate of 0.21